Challenges in the management of severe asymptomatic aortic stenosis

Andrew Owen1, Michael Y Henein

  • 1Canterbury Christ Church University, Canterbury, UK.

Insights

For severe asymptomatic aortic stenosis, early aortic valve replacement may offer better long-term outcomes than a watch-and-see approach. This strategy considers potential irreversible heart damage from untreated stenosis.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Medicine

Background:

  • Symptomatic aortic stenosis treatment is aortic valve replacement.
  • Optimal management for severe asymptomatic aortic stenosis remains unclear, lacking randomized controlled trials.
  • Current guidelines suggest monitoring asymptomatic patients until symptoms arise, with exceptions for specific criteria like severe left-ventricular hypertrophy.

Purpose of the Study:

  • To evaluate the optimal management strategy for severe asymptomatic aortic stenosis.
  • To consider the long-term consequences of left-ventricular remodeling in asymptomatic aortic stenosis.
  • To propose an alternative management approach for severe asymptomatic aortic stenosis.

Main Methods:

  • Review of current guidelines and observational studies.
  • Analysis of risks associated with a "watch-and-see" approach.
  • Comparison of outcomes between early and deferred aortic valve replacement.

Main Results:

  • Asymptomatic patients have a low risk of sudden death, but "watch-and-see" may lead to irreversible left-ventricular remodeling.
  • Observational data suggests superior long-term outcomes with early aortic valve replacement compared to delayed surgery.
  • No randomized controlled trials exist to definitively guide management.

Conclusions:

  • Clinicians should consider early aortic valve replacement for severe asymptomatic aortic stenosis.
  • The potential for irreversible cardiac damage warrants consideration beyond symptom development.
  • Further research, including randomized trials, is needed to establish definitive guidelines.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...